Attached files
file | filename |
---|---|
10-K - 10-K - Sarepta Therapeutics, Inc. | a09-35851_110k.htm |
EX-31.1 - EX-31.1 - Sarepta Therapeutics, Inc. | a09-35851_1ex31d1.htm |
EX-23.1 - EX-23.1 - Sarepta Therapeutics, Inc. | a09-35851_1ex23d1.htm |
EX-31.2 - EX-31.2 - Sarepta Therapeutics, Inc. | a09-35851_1ex31d2.htm |
EX-21.1 - EX-21.1 - Sarepta Therapeutics, Inc. | a09-35851_1ex21d1.htm |
EX-10.78 - EX-10.78 - Sarepta Therapeutics, Inc. | a09-35851_1ex10d78.htm |
EXHIBIT 32.1
CERTIFICATION OF CEO AND CFO PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of AVI BioPharma, Inc. (the Company) on Form 10-K for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Leslie Hudson, Ph.D., as Chief Executive Officer of the Company, and J. David Boyle II, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge,:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/ Leslie Hudson, Ph.D. |
|
Leslie Hudson, Ph.D. |
|
President, Chief Executive Officer and Director |
|
AVI BioPharma, Inc. |
|
March 16, 2010 |
|
/s/ J. David Boyle II |
|
J. David Boyle II |
|
Senior Vice President and Chief Financial Officer |
|
AVI BioPharma, Inc. |
|
March 16, 2010 |
|
This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
See also the certification pursuant to Sec. 302 of the Sarbanes-Oxley Act of 2002, which is also attached to this Report.